19930309
 Warner-Lambert takes third swing at FDA approval for Alzheimer's drug   By Waldholz, Michael, The Wall Street Journal,  Mar 10, 1993  Pharmaceutical concern Warner-Lambert Co, for the third time in two years, is trying to get FDA approval for its Alzheimer's disease drug, Cognex. The company will present federal regulators with the results of a new study of the drug to an advisory panel of experts at a Mar 18, 1993 meeting.   
